These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9102228)

  • 1. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
    Gross N; Balmas K; Brognara CB
    Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD44H carbohydrate structure in neuroblastoma adhesive properties.
    Gross N; Balmas K; Beretta Brognara C
    Med Pediatr Oncol; 2001 Jan; 36(1):139-41. PubMed ID: 11464867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells.
    Gross N; Balmas Bourloud K; Brognara CB
    Exp Cell Res; 2000 Nov; 260(2):396-403. PubMed ID: 11035936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
    English NM; Lesley JF; Hyman R
    Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody.
    Lesley J; Kincade PW; Hyman R
    Eur J Immunol; 1993 Aug; 23(8):1902-9. PubMed ID: 7688309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
    Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
    J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
    Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
    Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of class I histocompatibility antigens in neuroectodermal tumors is independent of the expression of a transfected neuroblastoma myc gene.
    Feltner DE; Cooper M; Weber J; Israel MA; Thiele CJ
    J Immunol; 1989 Dec; 143(12):4292-9. PubMed ID: 2687378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
    Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
    Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
    Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway.
    Ishida O; Tanaka Y; Morimoto I; Takigawa M; Eto S
    J Bone Miner Res; 1997 Oct; 12(10):1657-63. PubMed ID: 9333126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4.
    Kryworuchko M; Gee K; Diaz-Mitoma F; Kumar A
    Cell Immunol; 1999 May; 194(1):54-66. PubMed ID: 10357881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.
    Lesley J; Hyman R
    Eur J Immunol; 1992 Oct; 22(10):2719-23. PubMed ID: 1382996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases.
    Gee K; Kryworuchko M; Kumar A
    Arch Immunol Ther Exp (Warsz); 2004; 52(1):13-26. PubMed ID: 15053229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion.
    Mohamadzadeh M; DeGrendele H; Arizpe H; Estess P; Siegelman M
    J Clin Invest; 1998 Jan; 101(1):97-108. PubMed ID: 9421471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential binding of hyaluronan on the surface of tissue-specific endothelial cell lines.
    Szczepanek K; Kieda C; Cichy J
    Acta Biochim Pol; 2008; 55(1):35-42. PubMed ID: 18231653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
    Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
    J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid inhibits adhesion of hepatic stellate cells in spite of its stimulation of DNA synthesis.
    Cho MK; Lee GH; Park EY; Kim SG
    Tissue Cell; 2004 Oct; 36(5):293-305. PubMed ID: 15385147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.
    Murakami S; Shimabukuro Y; Miki Y; Saho T; Hino E; Kasai D; Nozaki T; Kusumoto Y; Okada H
    J Immunol; 1994 Jan; 152(2):467-77. PubMed ID: 7506725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.